Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
Aegis’ Intravail® drug delivery technology utilized in Neurelis’ VALTOCO™ Nasal Spray, a novel investigational treatment for epilepsy patients SAN DIEGO, CA – December 3, 2018 — Neurelis, Inc. today announced the acquisition of Aegis Therapeutics, a San Diego-based drug delivery technology company. Aegis Therapeutics’ proprietary portfolio includes Intravail®, ProTek® and Hydrogel™, three non-invasive drug delivery […]